Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Jihoon Kim, Jae Hung Jung, Halim Jo, Myung Ha Kim, Dae Ryong Kang & Hee Man Kim. (2023) Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis. Scandinavian Journal of Gastroenterology 58:12, pages 1412-1421.
Read now
Read now
Benoit Follin-Arbelet, Milada Cvancarova Småstuen, Øistein Hovde, Lars-Petter Jelsness-Jørgensen & Bjørn Moum. (2023) Incidence of cancer in patients with ulcerative colitis 30 years after diagnosis (the IBSEN study). Scandinavian Journal of Gastroenterology 58:11, pages 1264-1270.
Read now
Read now
Anoud Haddad, Mohammed Qussay Al-Sabbagh, Hashim Al-Ani, Abdel Muez Siyam, Emad Aborajooh, Takehiro Iwata, Shoji Kimura, Shahrokh F. Shariat & Mohammad Abufaraj. (2020) Inflammatory bowel disease and prostate cancer risk: A systematic review. Arab Journal of Urology 18:4, pages 207-212.
Read now
Read now
Essi K. Karjalainen, Laura Renkonen-Sinisalo & Anna H. Lepistö. (2020) Dysplasia in the mucosal biopsy specimen is still a warning sign of cancer in ulcerative colitis. Scandinavian Journal of Gastroenterology 55:9, pages 1019-1023.
Read now
Read now
James H. Tabibian & Todd H. Baron. (2018) Endoscopic management of primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 12:7, pages 693-703.
Read now
Read now
Marcello Maida, Fabio Salvatore Macaluso, Gianluca Ianiro, Francesca Mangiola, Emanuele Sinagra, Georgina Hold, Carlo Maida, Giovanni Cammarota, Antonio Gasbarrini & Giuseppe Scarpulla. (2017) Screening of colorectal cancer: present and future. Expert Review of Anticancer Therapy 17:12, pages 1131-1146.
Read now
Read now
M. Artama, S. Heinävaara, T. Sarkeala, R. Prättälä, E. Pukkala & N. Malila. (2016) Determinants of non-participation in a mass screening program for colorectal cancer in Finland. Acta Oncologica 55:7, pages 870-874.
Read now
Read now
Johan Burisch & Pia Munkholm. (2015) The epidemiology of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:8, pages 942-951.
Read now
Read now
Alyssa Parian & Mark Lazarev. (2015) Who and how to screen for cancer in at-risk inflammatory bowel disease patients. Expert Review of Gastroenterology & Hepatology 9:6, pages 731-746.
Read now
Read now
Pia Manninen, Anna-Liisa Karvonen, Johanna Laukkarinen, Petri Aitola, Heini Huhtala & Pekka Collin. (2015) Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:4, pages 423-428.
Read now
Read now
Urpo Nieminen & Martti Färkkilä. (2015) Malignancies in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:1, pages 81-89.
Read now
Read now
James H. Tabibian, Steven P. O’Hara & Keith D. Lindor. (2014) Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies. Scandinavian Journal of Gastroenterology 49:8, pages 901-908.
Read now
Read now
Articles from other publishers (54)
Ola Olén, Karin E. Smedby, Rune Erichsen, Lars Pedersen, Jonas Halfvarson, Åsa Hallqvist-Everhov, Nicklas Bryder, Johan Askling, Anders Ekbom, Michael C. Sachs, Henrik Toft Sørensen, Jonas F. Ludvigsson, Malin Olsson, Pär Myrelid, Henrik Hjortswang, Jonas Bengtsson, Hans Strid, Marie Andersson, Susanna Jäghult, Michael Eberhardson, Caroline Nordenvall, Jan Björk, Martin Rejler, Olof Grip, Ulrika L. Fagerberg & Pontus Karling. (2023) Increasing Risk of Lymphoma Over Time in Crohn’s Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study. Clinical Gastroenterology and Hepatology 21:12, pages 3132-3142.
Crossref
Crossref
Özlem KAYACIK GÜNDAY, Gökçe ZEYTİN DEMİRAL, Şerafettin BAYSAL, Tacettin SEVİM, Selin YOLDAŞ, Berkay ÇELEBİ & Ensar ÇAM. (2023) MULTİPL SKLEROZ HASTALARINDA SERVİKAL DİSPLAZİ RİSKİCERVICAL DYSPLASIA RISK IN MULTIPLE SCLEROSIS PATIENTS. Kocatepe Tıp Dergisi 24:4, pages 493-499.
Crossref
Crossref
Benoit Follin-Arbelet, Milada Cvancarova Småstuen, Øistein Hovde, Lars-Petter Jelsness-Jørgensen & Bjørn Moum. (2023) Risk of Cancer in Patients With Crohn’s Disease 30 Years After Diagnosis (the IBSEN Study). Crohn's & Colitis 360 5:4.
Crossref
Crossref
Yash R Shah, Natalia Nombera-Aznaran, David Guevara-Lazo, Ernesto Calderon-Martinez, Angad Tiwari, SriLakshmiDevi Kanumilli, Purva Shah, Bhanu Siva Mohan Pinnam, Hassam Ali & Dushyant Singh Dahiya. (2023) Liver transplant in primary sclerosing cholangitis: Current trends and future directions. World Journal of Hepatology 15:8, pages 939-953.
Crossref
Crossref
Alessandro Massano, Luisa Bertin, Fabiana Zingone, Andrea Buda, Pierfrancesco Visaggi, Lorenzo Bertani, Nicola de Bortoli, Matteo Fassan, Marco Scarpa, Cesare Ruffolo, Imerio Angriman, Cristina Bezzio, Valentina Casini, Davide Giuseppe Ribaldone, Edoardo Vincenzo Savarino & Brigida Barberio. (2023) Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review. Cancers 15:15, pages 3824.
Crossref
Crossref
Wen Cheng, Yang Liao, Ruiyu Mou, Xian Xiao & Yingjie Jia. (2023) Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis. Frontiers in Immunology 14.
Crossref
Crossref
Ben‐Gang Zhou, Qi Yu, Xin Jiang, Yu-Zhou Mei, Yan-Bing Ding & Mei Wang. (2023) Association between inflammatory bowel disease and risk of incident prostate cancer: a systematic review and meta-analysis of cohort studies. International Journal of Colorectal Disease 38:1.
Crossref
Crossref
Jihoon Kim, Halim Jo, Min Chul Ha, Hyunil Kim, Jung Kuk Lee, Jae Hun Han, San-Hui Lee, Dae Ryong Kang, Su Young Kim, Hyun-Soo Kim & Hee Man Kim. (2023) Elevated risk of cervical cancer in elderly women with incident ulcerative colitis in South Korea. Scientific Reports 13:1.
Crossref
Crossref
Maria Francesca Russo, Annalisa Diddoro, Alessandra Iodice, Carola Severi, Lidia Castagneto-Gissey & Giovanni Casella. (2023) Incidence of lymphomas in inflammatory bowel disease: report of an emblematic case, systematic review, and meta-analysis. Frontiers in Medicine 10.
Crossref
Crossref
Hee Man Kim, Jihoon Kim, Hyunil Kim, Soon Chang Park, Jung Kuk Lee, Dae Ryong Kang, Su Young Kim & Hyun-Soo Kim. (2023) Risk of Gastric Cancer among Patients with Newly Diagnosed Ulcerative Colitis: A Nationwide Population-Based Study. Journal of Clinical Medicine 12:8, pages 2843.
Crossref
Crossref
Ping-Jui Yu, Cheng-Maw Ho, Chih-Yang Hsiao, Yao-Ming Wu, Ming-Chih Ho, Po-Huang Lee & Rey-Heng Hu. (2023) Longitudinal analysis of transplant candidates with primary sclerosing cholangitis in an Asian liver transplant center. European Journal of Gastroenterology & Hepatology 35:4, pages 480-487.
Crossref
Crossref
Andreia Albuquerque, Carmelina Cappello, Oliver Stirrup & Christian P Selinger. (2023) Anal High-risk Human Papillomavirus Infection, Squamous Intraepithelial Lesions, and Anal Cancer in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis.
Crossref
Crossref
Huimin Zhang, Mengmeng Zhang, Xuanfu Chen, Mingyue Guo, Runing Zhou, Hong Lv, Yue Li, Bei Tan, Ji Li, Hui Xu, Weiyang Zheng, Hong Yang & Jiaming Qian. (2022) Risk of malignancy in patients with inflammatory bowel disease: A population‐based cohort study from China. International Journal of Cancer 150:11, pages 1770-1778.
Crossref
Crossref
Rahma Elmahdi, Louise T. Thomsen, Aske T. Iversen, Kristine H. Allin, Susanne K. Kjær & Tine Jess. (2022) Increased risk of genital warts in inflammatory bowel disease: A Danish registry‐based cohort study (1996–2018). United European Gastroenterology Journal 10:3, pages 287-295.
Crossref
Crossref
Jingru Yu, Erle Refsum, Lise M. Helsingen, Trine Folseraas, Alexander Ploner, Paulina Wieszczy, Ishita Barua, Henriette C. Jodal, Espen Melum, Magnus Løberg, Johannes Blom, Michael Bretthauer, Hans‐Olov Adami, Mette Kalager & Weimin Ye. (2022) Risk of hepato‐pancreato‐biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population‐based cohort study. United European Gastroenterology Journal 10:2, pages 212-224.
Crossref
Crossref
Can Gong, Renyuan Xu, Ping Zou, Yuna Zhang & Xiaodong Wang. (2021) Inflammatory bowel disease and risk of breast cancer: a meta-analysis of cohort studies. European Journal of Cancer Prevention 31:1, pages 54-63.
Crossref
Crossref
Anastasia Mala, Kalliopi Foteinogiannopoulou & Ioannis E Koutroubakis. (2021) Solid extraintestinal malignancies in patients with inflammatory bowel disease. World Journal of Gastrointestinal Oncology 13:12, pages 1956-1980.
Crossref
Crossref
Mirabella Zhao, Lóránt Gönczi, Peter L Lakatos & Johan Burisch. (2021) The Burden of Inflammatory Bowel Disease in Europe in 2020. Journal of Crohn's and Colitis 15:9, pages 1573-1587.
Crossref
Crossref
Gian Paolo Caviglia, Giorgio Martini, Angelo Armandi, Chiara Rosso, Marta Vernero, Elisabetta Bugianesi, Marco Astegiano, Giorgio Maria Saracco & Davide Giuseppe Ribaldone. (2021) Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease. Journal of Clinical Medicine 10:15, pages 3257.
Crossref
Crossref
Bobby Lo, Mirabella Zhao, Ida Vind & Johan Burisch. (2021) The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Cohort Studies. Clinical Gastroenterology and Hepatology 19:6, pages 1117-1138.e19.
Crossref
Crossref
Zhihua Geng & Qing Geng. (2021) Risk of Urinary Bladder Cancer in Patients With Inflammatory Bowel Diseases: A Meta-Analysis. Frontiers in Surgery 8.
Crossref
Crossref
Federica Gaiani, Federica Marchesi, Francesca Negri, Luana Greco, Alberto Malesci, Gian Luigi de’Angelis & Luigi Laghi. (2021) Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes. International Journal of Molecular Sciences 22:10, pages 5246.
Crossref
Crossref
Rui Zhao, Qian-Yi Wan, Yutao Wu, Yong Wang, Ya-Ping Cui, Xiaoding Shen & Xiao Ting Wu. (2021) Crohn’s disease instead of UC might increase the risk of small bowel cancer. Gut 70:4, pages 809-810.
Crossref
Crossref
Qianyi Wan, Rui Zhao, Lin Xia, Yutao Wu, Yong Zhou, Yong Wang, Yaping Cui, Xiaoding Shen & Xiao-Ting Wu. (2021) Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies. Journal of Cancer Research and Clinical Oncology 147:4, pages 1077-1087.
Crossref
Crossref
Dechao Feng, Yunjin Bai, Shengzhuo Liu, Yubo Yang, Ping Han & Wuran Wei. (2021) Risk of renal cancer in patients with inflammatory bowel disease: A pooled analysis of population-based studies. Urologic Oncology: Seminars and Original Investigations 39:2, pages 93-99.
Crossref
Crossref
Virginia Solitano, Ferdinando D’Amico, Carmen Correale, Laurent Peyrin-Biroulet & Silvio Danese. (2020) Thiopurines and non-melanoma skin cancer: partners in crime in inflammatory bowel diseases. British Medical Bulletin 136:1, pages 107-117.
Crossref
Crossref
Mahsa Ghajarzadeh, Aida Mohammadi & Mohammad Ali Sahraian. (2020) Risk of cancer in multiple sclerosis (MS): A systematic review and meta-analysis. Autoimmunity Reviews 19:10, pages 102650.
Crossref
Crossref
Edoardo Carli, Gian Paolo Caviglia, Rinaldo Pellicano, Sharmila Fagoonee, Stefano Rizza, Marco Astegiano, Giorgio Maria Saracco & Davide Giuseppe Ribaldone. (2020) Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis. Medicina 56:6, pages 285.
Crossref
Crossref
Muhammad B. HammamiUma Mahadevan. (2020) Men With Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer. American Journal of Gastroenterology 115:4, pages 526-534.
Crossref
Crossref
Yuqiu Ge, Qianqian Shi, Wenxi Yao, Yang Cheng & Gaoxiang Ma. (2019) The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis. Prostate Cancer and Prostatic Diseases 23:1, pages 53-58.
Crossref
Crossref
Thomas Greuter, Stephan Vavricka, Alexander O. König, Laurent Beaugerie & Michael Scharl. (2020) Malignancies in Inflammatory Bowel Disease. Digestion 101:Suppl. 1, pages 136-145.
Crossref
Crossref
Veronica Ranieri, Eilis Kennedy, Martine Walmsley, Doug Thorburn & Kathy McKay. (2019) Rare but heard: using asynchronous virtual focus groups, interviews and roundtable discussions to create a personalised psychological intervention for primary sclerosing cholangitis: a protocol. BMJ Open 9:10, pages e031417.
Crossref
Crossref
Shirley Cohen-Mekelburg, Yecheskel Schneider, Stephanie Gold, Gaurav Ghosh, Russell Rosenblatt, Kaveh Hajifathalian, Ellen Scherl, Felice Schnoll-Sussman, Philip Katz & Adam Steinlauf. (2019) Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care. Digestive Diseases and Sciences 64:8, pages 2273-2279.
Crossref
Crossref
Lihong Cao. (2018) Assessment of thyroid cancer risk in more than 334,000 patients with inflammatory bowel disease: a case-control study and a meta-analysis. World Journal of Surgical Oncology 16:1.
Crossref
Crossref
Babak Torabi Sagvand, Katelyn Edwards & Bo Shen. (2018) Frequency, Risk Factors, and Outcome of Gallbladder Polyps in Patients With Primary Sclerosing Cholangitis: A Case‐Control Study. Hepatology Communications 2:12, pages 1440-1445.
Crossref
Crossref
James H. Tabibian & Christopher L. Bowlus. (2018) WITHDRAWN: Primary sclerosing cholangitis: A review and update. Liver Research.
Crossref
Crossref
Kais Zakharia, Anilga Tabibian, Keith D. Lindor & James H. Tabibian. (2018) Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver International 38:3, pages 399-411.
Crossref
Crossref
Sae Jung Na, Min Ji Kang, Dong Soo Yu, Kyung-Do Han, Ji Hyun Lee, Yong Gyu Park & Young Bok Lee. (2018) Cancer risk in patients with Behçet disease: A nationwide population-based dynamic cohort study from Korea. Journal of the American Academy of Dermatology 78:3, pages 464-470.e2.
Crossref
Crossref
Gian Luigi de’Angelis, Federica Gaiani & Nicola de’Angelis. 2018. Endoscopy in Pediatric Inflammatory Bowel Disease. Endoscopy in Pediatric Inflammatory Bowel Disease
71
100
.
James H. Tabibian & Christopher L. Bowlus. (2017) Primary sclerosing cholangitis: A review and update. Liver Research 1:4, pages 221-230.
Crossref
Crossref
Peter S. Kirk, Shail Govani, Tudor Borza, Brent K. Hollenbeck, Jennifer Davis, Dean Shumway, Akbar K. Waljee & Ted A. Skolarus. (2017) Implications of Prostate Cancer Treatment in Men With Inflammatory Bowel Disease. Urology 104, pages 131-136.
Crossref
Crossref
James H. Tabibian, Konstantinos N. Lazaridis & Nicholas F. LaRusso. 2017. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set
663
674.e5
.
Øistein Hovde, Marte Lie Høivik, Magne Henriksen, Inger Camilla Solberg, Milada Cvancarova Småstuen & Bjørn A. Moum. (2016) Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study. Journal of Crohn's and Colitis, pages jjw193.
Crossref
Crossref
Konstantinos N. Lazaridis & Nicholas F. LaRusso. (2016) Primary Sclerosing Cholangitis. New England Journal of Medicine 375:12, pages 1161-1170.
Crossref
Crossref
Tim R.A. van den Heuvel, Dion S.J. Wintjens, Steven F.G. Jeuring, Maartje H.H. Wassink, Marielle J.L. Romberg-Camps, Liekele E. Oostenbrug, Silvia Sanduleanu, Wim H. Hameeteman, Maurice P. Zeegers, Ad A. Masclee, Daisy M. Jonkers & Marie J. Pierik. (2016) Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort. International Journal of Cancer 139:6, pages 1270-1280.
Crossref
Crossref
Magnus Hofrenning Wanderås, Bjørn A Moum, Marte Lie Høivik & Øistein Hovde. (2016) Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies. World Journal of Gastrointestinal Pharmacology and Therapeutics 7:2, pages 235.
Crossref
Crossref
Chelle L. Wheat, Kindra Clark-Snustad, Beth Devine, David Grembowski, Timothy A. Thornton & Cynthia W. Ko. (2016) Worldwide Incidence of Colorectal Cancer, Leukemia, and Lymphoma in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis. Gastroenterology Research and Practice 2016, pages 1-18.
Crossref
Crossref
Luca Roncucci & Francesco Mariani. (2015) Prevention of colorectal cancer: How many tools do we have in our basket?. European Journal of Internal Medicine 26:10, pages 752-756.
Crossref
Crossref
Lauranne A.A.P. Derikx, Loes H.C. Nissen, Joost P.H. Drenth, Carla M. van Herpen, Wietske Kievit, Rob H.A. Verhoeven, Peter F.A. Mulders, Christina A. Hulsbergen-van de Kaa, Marye J. Boers-Sonderen, Tim R.A. van den Heuvel, Marieke Pierik, Iris D. Nagtegaal & Frank Hoentjen. (2015) Better survival of renal cell carcinoma in patients with inflammatory bowel disease. Oncotarget 6:35, pages 38336-38347.
Crossref
Crossref
Vito Annese, Laurent Beaugerie, Laurence Egan, Livia Biancone, Claus Bolling, Christian Brandts, Daan Dierickx, Reinhard Dummer, Gionata Fiorino, Jean Marc Gornet, Peter Higgins, Konstantinos H Katsanos, Loes Nissen, Gianluca Pellino, Gerhard Rogler, Franco Scaldaferri, Edyta Szymanska & Rami Eliakim. (2015) European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies. Journal of Crohn's and Colitis 9:11, pages 945-965.
Crossref
Crossref
James H. Tabibian, Ania Moradkhani & Mark D. Topazian. (2015) Colorectal cancer surveillance in primary sclerosing cholangitis and inflammatory bowel disease. Annals of Hepatology 14:4, pages 564-566.
Crossref
Crossref
Deepa Taggarshe, Bashir O. Attuwaybi, Brian Matier, Jeffrey J. Visco & Bryan N. Butler. (2015) Hand-Assisted Laparoscopic (HAL) Multiple Segmental Colorectal Resections: Are They Feasible and Safe?. International Surgery 100:4, pages 632-637.
Crossref
Crossref
Ruth Ann Marrie, Nadia Reider, Jeffrey Cohen, Olaf Stuve, Maria Trojano, Per Soelberg Sorensen, Stephen C Reingold & Gary Cutter. (2014) A systematic review of the incidence and prevalence of cancer in multiple sclerosis. Multiple Sclerosis Journal 21:3, pages 294-304.
Crossref
Crossref
C. Castaño-Milla, M. Chaparro & J. P. Gisbert. (2014) Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Alimentary Pharmacology & Therapeutics 39:7, pages 645-659.
Crossref
Crossref